Charles River Laboratories International (CRL) Amortization of Deferred Charges (2010 - 2016)

Charles River Laboratories International's Amortization of Deferred Charges history runs 7 years deep, the most recent figure standing at $506000.0 for Q4 2016.

• In Q4 2016, Amortization of Deferred Charges rose 23.41% year-over-year to $506000.0; the TTM figure through Dec 2016 stood at $2.8 million (up 18.95% YoY), while the FY2016 annual figure was $2.8 million, up 18.95% from the prior year.
• Amortization of Deferred Charges for Q4 2016 stood at $506000.0, up from $34000.0 in the prior quarter.
• The five-year high for Amortization of Deferred Charges was $4.6 million in Q1 2013, with the low at $34000.0 in Q3 2016.
• The 5-year median for Amortization of Deferred Charges is $436000.0 (2013), against an average of $1.7 million.
• The sharpest annual moves came in 2015 and 2016: Amortization of Deferred Charges jumped 165.36% in 2015, then plunged 91.46% in 2016.
• Charles River Laboratories International's Amortization of Deferred Charges stood at $4.5 million in 2012, then sank by 90.26% to $437000.0 in 2013, then fell by 2.29% to $427000.0 in 2014, then retreated by 3.98% to $410000.0 in 2015, then grew by 23.41% to $506000.0 in 2016.
• Business Quant data shows CRL's Amortization of Deferred Charges at $506000.0 in Q4 2016, $34000.0 in Q3 2016, and $1.9 million in Q2 2016.